471
Journals
1.6M
Articles
38.7M
Citations
291.7K
Authors

Most Cited Articles of Oncology in 2018

TitleJournalYearCitations
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCa-A Cancer Journal for Clinicians201841.6K
Cancer statistics, 2018Ca-A Cancer Journal for Clinicians201812K
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology20181.7K
Ovarian cancer statistics, 2018Ca-A Cancer Journal for Clinicians20181.3K
Fundamental Mechanisms of Immune Checkpoint Blockade TherapyCancer Discovery20181.3K
Inflammatory responses and inflammation-associated diseases in organsOncotarget20181.3K
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018European Journal of Cancer20181.1K
Tumour heterogeneity and resistance to cancer therapiesNature Reviews Clinical Oncology20181.1K
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trialLancet Oncology, The20181.1K
Chimeric antigen receptor T-cell therapy - assessment and management of toxicitiesNature Reviews Clinical Oncology20181.1K
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015Neuro-Oncology20181K
Targeting the IL-6/JAK/STAT3 signalling axis in cancerNature Reviews Clinical Oncology2018975
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal CancerJournal of Clinical Oncology2018938
Artificial intelligence in radiologyNature Reviews Cancer2018916
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2018897
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysisJAMA Oncology2018893
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease StudyJAMA Oncology2018875
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 TrialJAMA Oncology2018834
Non-coding RNA networks in cancerNature Reviews Cancer2018806
Circular RNAs in cancer: opportunities and challenges in the fieldOncogene2018794
The Impact of Dietary Fiber on Gut Microbiota in Host Health and DiseaseCell Host and Microbe2018786
Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer SocietyCa-A Cancer Journal for Clinicians2018759
Molecular therapies and precision medicine for hepatocellular carcinomaNature Reviews Clinical Oncology2018735
Revisiting the role of ABC transporters in multidrug-resistant cancerNature Reviews Cancer2018732
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapyLancet Oncology, The2018730